Newest Continuing Medical Education Live Events & Online Activities

How Can Pathologic Assessment Be Optimized for Patients With Acute Myeloid Leukemia? A Case-Based Discussion

01/22/2020

Naples, FL

Chair: Daniel A. Arber, MD

1.5 CME

The Impact of PI3K Inhibitors for the Treatment of Patients with Breast Cancer

Expires on 01/09/2021

Tiffany A. Traina, MD

0.5 CME

ASCO GI: A New Wave of Progress in Cholangiocarcinoma: Optimizing Outcomes from Diagnosis to Treatment

01/23/2020

San Francisco, CA

Chair: Ghassan K. Abou-Alfa, MD, MBA

2.0 CME

Community Practice Connections™: Precision Medicine in Oncology: Current Role and Future Potential of In-House NGS Technologies

Expires on 01/06/2021

Timothy Triche, MD, PhD; Leo Mascarenhas, MD, MS; Jaclyn Biegel, PhD

1.0 CME

ASCO GI: Exploring the Modern Management of Pancreatic Cancer: Therapeutic Sequencing, Chemotherapy, and Novel Agents

01/23/2020

San Francisco, CA

Chair: Shubham Pant, MD

2.0 CME

Cancer Summaries and Commentaries™: Report From Orlando on Advancements in Multiple Myeloma

Expires on 12/24/2020

Ajai Chari, MD; Shaji Kumar, MD

2.0 CME

ASCO GI: Exploitation of the DNA Damage Response and the Emerging Role of PARP Inhibition in Pancreatic Cancer

01/24/2020

San Francisco, CA

Chair: Eileen M. O’Reilly, MD

2.0 CME

Clinical Vignettes™: Addressing Challenging Clinical Scenarios in Lung Cancer

Expires on 12/24/2020

Mark G. Kris, MD; Alexander E. Drilon, MD; Roy S. Herbst, MD, PhD

1.0 CME

ASCO GI: Medical Crossfire®: Exploring HER2 Targeted Treatment Approaches for Gastrointestinal Cancers

01/24/2020

San Francisco, CA

Chair: David H. Ilson, MD, PhD

2.0 CME

Cancer Summaries and Commentaries™: Report from Orlando on Advances in the Treatment of GvHD

Expires on 12/24/2020

James L.M Ferrara, MD, DSc; Shernan Holtan, MD

1.5 CME

17th Annual Winter Lung Cancer Conference™

02/07/2020 - 02/09/2020

Miami, FL

Chairs: Rogerio C. Lilenbaum, MD; Mark A. Socinski, MD; Heather A. Wakelee, MD; Julie R. Brahmer, MD, MSc, FASCO

10.75 CME

10.75 CNE

Cancer Summaries and Commentaries™: Report from Orlando on Advances in the Treatment of CLL

Expires on 12/24/2020

Ian Flinn, MD, PhD; Susan O’Brien, MD

1.5 CME